These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33076721)

  • 41. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
    Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
    Zhu MH; Liu ZJ; Hu QY; Yang JY; Jin Y; Zhu N; Huang Y; Shi DH; Liu MJ; Tan HY; Zhao L; Lv QY; Yi ZH; Wu FC; Li ZZ
    Mil Med Res; 2022 Oct; 9(1):59. PubMed ID: 36253804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis.
    Olagunju AT; Clark SR; Baune BT
    CNS Drugs; 2018 Nov; 32(11):1011-1023. PubMed ID: 30155842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review of clozapine's effectiveness for primary psychotic and bipolar disorders in older adults.
    Renzenbrink M; Wand APF
    Int Psychogeriatr; 2022 Oct; 34(10):875-887. PubMed ID: 33612141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial.
    Berkhof M; van der Stouwe ECD; Lestestuiver B; Van't Hag E; van Grunsven R; de Jager J; Kooijmans E; Zandee CER; Staring ABP; Pot-Kolder RMCA; Vos M; Veling W
    BMC Psychiatry; 2021 Oct; 21(1):496. PubMed ID: 34635063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Individual cognitive behavioural therapy for psychosis (CBTp): a systematic review of qualitative literature.
    Wood L; Burke E; Morrison A
    Behav Cogn Psychother; 2015 May; 43(3):285-97. PubMed ID: 24308817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zotepine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006628. PubMed ID: 20091601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal Treatment Strategies of Clozapine for Refractory Schizophrenia.
    Li YY; Zhang YS; Wang J; Li KQ; Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):666-678. PubMed ID: 28065233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.
    Lally J; Tully J; Robertson D; Stubbs B; Gaughran F; MacCabe JH
    Schizophr Res; 2016 Mar; 171(1-3):215-24. PubMed ID: 26827129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of clozapine on hospital use: a systematic review and meta-analysis.
    Land R; Siskind D; McArdle P; Kisely S; Winckel K; Hollingworth SA
    Acta Psychiatr Scand; 2017 Apr; 135(4):296-309. PubMed ID: 28155220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Refractory schizophrenia].
    Elkis H; Meltzer HY
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S41-7. PubMed ID: 18157433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis.
    Ainsworth NJ; Avina-Galindo AM; White RF; Zhan D; Gregory EC; Honer WG; Vila-Rodriguez F
    Brain Stimul; 2022; 15(5):1184-1191. PubMed ID: 36028155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistance is not futile: treatment-refractory schizophrenia - overview, evaluation and treatment.
    Faden J; Citrome L
    Expert Opin Pharmacother; 2019 Jan; 20(1):11-24. PubMed ID: 30407873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.